NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
종목 코드 NIVF
회사 이름NewGenIvf Group Ltd
상장일Feb 15, 2022
CEOWing Fung (Siu)
직원 수76
유형Ordinary Share
회계 연도 종료Feb 15
주소13/F, Ps Tower, Sukhumvit 21 Rd (Asoke)
도시BANGKOK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Thailand
우편 번호- -
전화
웹사이트https://newgenivf.com/
종목 코드 NIVF
상장일Feb 15, 2022
CEOWing Fung (Siu)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음